Elisa Pierpaoli et al. 2022. Determination of Antimetastatic and Antitumor Activities of Orally Administered NAX014 Compound in a Murine Model of HER2-Positive Breast Cancer. Perspective of Recent Advances in Medical Research Vol. 2. (Dec. 2022), 109–127. DOI:https://doi.org/10.9734/bpi/pramr/v2/3905C.